Mukund M Mehrotra

Title: Mukund M Mehrotra: Innovator in Opioid Agonist Peptides

Introduction

Mukund M Mehrotra is a notable inventor based in Newark, CA (US). He has made significant contributions to the field of peptide synthesis and opioid research. With a total of two patents to his name, his work focuses on innovative methods and applications in the pharmaceutical industry.

Latest Patents

Mukund's latest patents include "Opioid agonist peptides and uses thereof," which is directed to opioid agonist peptides and their various applications. Another significant patent is "Methods for synthesizing α4β7 peptide antagonists," which provides methods for creating α4β7 peptide monomer and dimer antagonists. These methods encompass solid phase and solution phase techniques, as well as synthesis through the condensation of smaller peptide fragments. Additionally, his methods include the synthesis of peptides that contain one or more penicillamine residues.

Career Highlights

Throughout his career, Mukund has worked with Protagonist Therapeutics, Inc., a company known for its focus on peptide-based therapeutics. His expertise in peptide synthesis has positioned him as a valuable asset in the pharmaceutical sector.

Collaborations

Mukund has collaborated with notable professionals in his field, including Ashok Bhandari and Suresh Kumar Manthati. These collaborations have further enhanced his research and development efforts.

Conclusion

Mukund M Mehrotra's innovative work in opioid agonist peptides and peptide synthesis showcases his significant contributions to the pharmaceutical industry. His patents reflect a commitment to advancing medical science and improving therapeutic options.